Background: Real world data supporting the effectiveness of the COVID-19 vaccination strategy in the UK population is needed to guide health policy. This real-word data-driven evidence study of the UK COVID-19 Vaccination Programme in the Northwest London (NWL) population used a unique dataset established as part of the Gold Command Covid-19 response in NWL (iCARE https://imperialbrc.nihr.ac.uk/facilities/icare/), which included the pre-established Whole System Integrated Care (WSIC) data collated for the purposes of population health in the sector. Objective: To assess the early vaccine administration coverage and vaccine effectiveness and outcome data across an integrated care system of eight CCGs leveraging a unique population-level care...
Background: A high BMI has been associated with a reduced immune response to vaccination against inf...
BACKGROUND: While the vaccines against COVID-19 are highly effective, COVID-19 vaccine breakthrough ...
Introduction: In July and August 2021, the SARS-CoV-2 Delta variant dominated in Europe. Aim: Using ...
Background: On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Sy...
Objective To assess the early vaccine administration coverage and vaccine effectiveness and outcome ...
BACKGROUND: BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have been rapidly rolled ou...
Introduction The novel coronavirus SARS-CoV-2, which emerged in December 2019, has caused millions o...
OBJECTIVE: To compare the effectiveness of the BNT162b2 mRNA (Pfizer-BioNTech) and the ChAdOx1 (Oxfo...
OBJECTIVE: To estimate waning of covid-19 vaccine effectiveness over six months after second dose. D...
Introduction: The novel coronavirus SARS-CoV-2, which emerged in December 2019, has caused millions ...
Background: The BNT162b2 mRNA vaccine has been shown to be effective at preventing serious COVID-19 ...
Background: COVID-19 vaccines approved in the UK are highly effective in general population cohorts,...
Objective To estimate vaccine effectiveness for preventing covid-19 related hospital admission in in...
BACKGROUND: On 8 December 2020 NHS England administered the first COVID-19 vaccination. AIM: To desc...
Background Current UK vaccination policy is to offer future COVID-19 booster doses to individuals at...
Background: A high BMI has been associated with a reduced immune response to vaccination against inf...
BACKGROUND: While the vaccines against COVID-19 are highly effective, COVID-19 vaccine breakthrough ...
Introduction: In July and August 2021, the SARS-CoV-2 Delta variant dominated in Europe. Aim: Using ...
Background: On March 11, 2020 the World Health Organisation declared the Severe Acute Respiratory Sy...
Objective To assess the early vaccine administration coverage and vaccine effectiveness and outcome ...
BACKGROUND: BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have been rapidly rolled ou...
Introduction The novel coronavirus SARS-CoV-2, which emerged in December 2019, has caused millions o...
OBJECTIVE: To compare the effectiveness of the BNT162b2 mRNA (Pfizer-BioNTech) and the ChAdOx1 (Oxfo...
OBJECTIVE: To estimate waning of covid-19 vaccine effectiveness over six months after second dose. D...
Introduction: The novel coronavirus SARS-CoV-2, which emerged in December 2019, has caused millions ...
Background: The BNT162b2 mRNA vaccine has been shown to be effective at preventing serious COVID-19 ...
Background: COVID-19 vaccines approved in the UK are highly effective in general population cohorts,...
Objective To estimate vaccine effectiveness for preventing covid-19 related hospital admission in in...
BACKGROUND: On 8 December 2020 NHS England administered the first COVID-19 vaccination. AIM: To desc...
Background Current UK vaccination policy is to offer future COVID-19 booster doses to individuals at...
Background: A high BMI has been associated with a reduced immune response to vaccination against inf...
BACKGROUND: While the vaccines against COVID-19 are highly effective, COVID-19 vaccine breakthrough ...
Introduction: In July and August 2021, the SARS-CoV-2 Delta variant dominated in Europe. Aim: Using ...